News

Filter

Current filters:

Merck & CoResearch

1 to 9 of 144 results

Merck enters into collaboration with NGM to develop biologics

Merck enters into collaboration with NGM to develop biologics

24-02-2015

Pharma giant Merck & Co has entered into a collaboration with privately-held biotech company NGM Biopharmaceuticals…

BiotechnologyMerck & CoNGM BiopharmaceuticalsResearchUSA

NewLink earns $20 million Ebola vaccine milestone from Merck

19-02-2015

US biotech firm NewLink Genetics says it had received notification from pharma giant Merck & Co that…

BiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesVaccines

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

19-02-2015

Positive data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first…

BiosimilarsBiotechnologyGastro-intestinalsHospiraInflectraJohnson & JohnsonMerck & CoRemicadeResearch

Health management program from Practice Fusion and Merck encourages vaccine uptake

Health management program from Practice Fusion and Merck encourages vaccine uptake

16-01-2015

Cloud-based electronic record service Practice Fusion and pharma giant Merck & Co have collaborated on…

MedicineMerck & CoPractice FusionResearchVaccines

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Merck & Co updates on plans to accelerate new drug submissions and future growth

Merck & Co updates on plans to accelerate new drug submissions and future growth

13-01-2015

US pharma giant Merck & Co has reported on the ongoing execution of its multi-year, strategic initiative…

Anti-viralsgrazoprevir/elbasvirKeytrudaMerck & CoOncologyPharmaceuticalRegulationResearchUSA

Merck and NewLink Ebola vaccine trial to resume after suspension

Merck and NewLink Ebola vaccine trial to resume after suspension

06-01-2015

The Phase I trial of pharma giant Merck & Co’s Ebola vaccine VSV-ZEBOV, developed in conjunction with…

Merck & CoNewLink GeneticsPharmaceuticalResearchSwitzerlandVaccinesVSV-ZEBOV

NewLink Genetic and Merck Ebola collaboration gets $30 million government award

23-12-2014

US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

1 to 9 of 144 results

COMPANY SPOTLIGHT

Menarini

Back to top